The morphogenetic signaling network responsible for gut-airway separation 209
As mentioned above, a limited number of morphogenetic signaling pathways is used in 210 patterning the tissues of our body. The major known morphogenetic pathways are all involved 211 in endodermal-mesenchymal interactions during esophageal development. As we will review 212 below there is a noticeable difference in the role of the various signaling pathways between 213 the developing esophagus and airways and many signaling defects in the pathways discussed 214 below lead either to a preferential esophageal or a predominant airway phenotype. For clarity 215 we will discuss the pathway separately but try to indicate interactions between the different 216 pathways where these are known. We will focus on phenotypes in mouse models as these are 217 often more insightful than mutations in humans, where the many important mutations are 218 missed due to embryonic lethality, patients are rare and difficult to characterize at the 219 molecular level due to the inability to obtain tissue. For an excellent overview of the human 220 mutations that result in foregut phenotypes we refer to recent reviews. 
240

Gli3
+/-mice that survive until later stages of development only a very small proximal 241 esophageal remnant can be observed and the mice lack both trachea and lungs. 242
The striking similarity between Shh and Sox2 mutant mice suggests that these factors are 243 functionally related. 
Murine esophageal epithelium 377
In contrast to the rest of the gastrointestinal tract, which is covered with a single layer of 378 columnar epithelium, the esophagus is lined with a multilayered squamous epithelium (figure 379
2). This epithelial phenotype is reflective of its role to transport rather than modify and absorb 380 luminal content. The esophageal epithelium in the mouse is constantly renewed from a 381 population of cells that are neatly organized with their nuclei perpendicular to the basement 382 membrane, the so called basal layer. 
Grp78
-/-mice.(73) UPR activation in response to conditional deletion of a major ERchaperone Grp78 in esophageal epithelium of these mice resulted in rapid differentiation 500 followed by repopulation of the epithelium from the non-recombined wild type cells, as was 501 found in intestinal epithelium.(25) This suggests that also in the esophageal epithelium the 502 UPR may serve as a quality control mechanism which forces progenitor cells with 503 accumulated unfolded proteins to initiate differentiation. 504
505
Esophageal epithelial pathophysiology, the development of Barrett's esophagus 506
Although the focus of this review is on the pathways that maintain esophageal epithelial 507 homeostasis and we have limited insight into how these pathways are deregulated during 508 carcinogenesis, we will briefly review the available data on how the signaling pathways 509 discussed above have been implicated in the development of Barrett's esophagus, the 510 precursor to esophageal adenocarcinoma.(64, 74) For a broader review on Barrett's esophagus 511 we refer to recently published reviews.(15, 80) 512
The development of esophageal adenocarcinoma occurs in a step-wise manner that is 513 relatively well characterized. The major risk factor for the development of esophageal 514 adenocarcinoma is gastroesophageal reflux disease (GERD). In GERD, the lower esophageal 515 sphincter fails to prevent reflux of gastric content, thereby leading to exposure of the 516 esophageal epithelium to gastric acid and bile acids. This can eventually lead to the 517 development of chronic esophageal inflammation and ulceration. In a subset of patients with 518 esophagitis, the stratified squamous epithelium at the gastroesophageal junction is converted 519 to intestinal-type columnar epithelium, a process called metaplasia. This intestinal metaplasia 520 is called Barrett's esophagus and is a precursor lesion for the development of 521 adenocarcinoma. Population based studies have shown that Barrett's esophagus is present in 522 0.5-1.5% of the Western population.(15) The progression of Barrett's epithelium to 523 adenocarcinoma again occurs in a well-established step-wise fashion in which the epithelium 524 will first develop areas of low-grade dysplasia, which progresses to high-grade dysplasia and 525 cancer. The risk of developing esophageal adenocarcinoma is very low (between 0.05-0.5% 526 per year for non-dysplastic metaplasia(15)) but increases steeply as the epithelium progresses 527 from normal epithelium to low-grade and high-grade dysplasia. 528
The molecular mechanism of the conversion of normal esophageal epithelium to intestinal 529 metaplasia is incompletely understood and it is not known if the metaplastic epithelium is 530 derived from the normal esophageal epithelium, arises from gastric cardia stem cells(66) or 531 from remnant embryonic epithelial cells that persist at the gastroesophageal junction as has 532 also been proposed.(93) Below we will discuss some of the pathways that may play a role in 533 the development of Barrett's esophagus. 534
Genetic predisposition. Genome wide association studies (GWAS) that examined genetic 535 predisposition to the development of Barrett's esophagus have implicated several pathways 536 with a role in the development of the esophagus.(38, 62, 81) One of the most significant 537 associations with the development of Barrett's esophagus found in the first large GWAS is a 538 single nucleotide polymorphism that is very close to FOXF1,(81) the mesenchymally 539 expressed Hedgehog target that acts upstream of BMP4 during development (see above). 540 Although, it was described that several transcription factors that regulate expression of 541 FOXF1 bind in the region that is in linkage disequilibrium with the associated SNP, it is not 542 yet clear how the risk allele affects FOXF1 expression. Given the role of BMP4 in the 543 development of Barrett's esophagus described below it could be speculated that the FOXF1 544 risk allele may act to increase stromal BMP4 expression, however this has not yet been 545
investigated. 546
A subsequent large GWAS identified a further two transcriptional regulators with a key role 547 in development in the risk to develop Barrett's esophagus. (38) The first is FOXP1. hierarchy,(32) as is found in for example the small intestine. In the following paragraphs we 622 will try to summarize the evidence presented for the two hypotheses. We will restrict 623 ourselves to the potential presence of stem cell population(s) during homeostasis as even less 624 is known about the behavior of potential stem cells during wound repair and carcinogenesis.
To avoid confusion in nomenclature we will use a description to define a dedicated tissue 626 stem cell as follows: a tissue-specific stem cell has the ability to generate new stem cells, i.e. 627 has self-renewal capacity and is capable of generating all the cell types present in a tissue, i.e. 628 has tissue-renewal capacity. Of note, these characteristics are, in our opinion, independent of 629 the cycling time and/or label-retaining characteristics of these cells. It should be mentioned 630
here that the well characterized Lgr5+ stem cells of the small intestine cycle once every 24 631 hours and can be considered fast cycling. 
